Comparing Remicade vs Ustekinumab
Remicade (infliximab) | Ustekinumab |
|
---|
Remicade (infliximab) | Ustekinumab |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Ulcerative Colitis, Crohn's Disease, Crohn's Disease - Active, Ankylosing Spondylitis, Inflammatory Bowel Disease, Plaque Psoriasis, Psoriasis, Psoriatic Arthritis, Rheumatoid... View more |
Prescription only
Prescribed for Crohn's Disease - Active, Crohn's Disease, Psoriasis, Plaque Psoriasis, Psoriatic Arthritis, Ulcerative Colitis, Ulcerative Colitis - Active. Ustekinumab may also be used for purposes... View more |
Related suggestions Ulcerative Colitis
|
|||||||
More about Remicade (infliximab) | More about Ustekinumab | ||||||||
Ratings & Reviews | |||||||||
Remicade has an average rating of 7.0 out of 10 from a total of 213 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 20% reported a negative effect. |
Ustekinumab has an average rating of 7.5 out of 10 from a total of 268 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 16% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Remicade side effects |
View all Ustekinumab side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Remicade prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
N/A |
||||||||
Brand Names | |||||||||
Other infliximab brands include: Avsola, Inflectra, Ixifi, Renflexis, Zymfentra | Imuldosa, Otulfi, Pyzchiva, Selarsdi, Stelara, Steqeyma, Wezlana, Yesintek | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
228 hours |
1291.2 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 566 drugs are known to interact with Remicade:
|
A total of 535 drugs are known to interact with Ustekinumab:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
August 24, 1998 |
September 25, 2009 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.